Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Vivos Therapeutics Inc
VVOS | US
0.90
USD-0.13
-13.02%
VVOS | US
Loading StockChartView...
About Vivos Therapeutics Inc
Sector
Healthcare
Industry
Medical Devices
Earnings date
30/06/2024
As of date
23/04/2026
Close
0.90
Open
1.05
High
1.05
Low
0.82
Vivos Therapeutics Inc. a medical technology company develops and commercializes treatment alternatives for patients with dentofacial abnormalities obstructive sleep apnea (OSA) and snoring in adults. It offers The Vivos Method a non-invasive non-surgical non-pharmaceutical multi-disciplinary treatment modality for the treatment of dentofacial abnormalities OSA and snoring. The company also offers VivoScore Program a screening and home sleep test in adults and children. It markets and sells its appliances and related treatments and services to licensed professionals primarily general dentists in the United States and Canada. The company was founded in 2016 and is based in Littleton Colorado.
View LessVVOS | US
Risk
132.0
Sharpe
-0.70
Luna's Score
39/100
Recommendation
Sell
Luna says (VVOS | US)
What's Working
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
169.9%1 month
132.0%3 months
90.7%6 months
87.1%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.90
Debt to equity
0.28
Debt to assets
0.11
Ent. to EBITDA
-0.21
Ent. to rev.
0.49
PEG
-
Other Fundamentals
EBITDA
-12.90M
MarketCap
4.27M
MarketCap(USD)
4.27M
Div. yield
-
Op. margin
-47.76
Erngs. growth
-
Rev. growth
19.40
Ret. on equity
-284.96
Short ratio
0.02
Short perc.
1.99
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.72
Range1M
0.72
Range3M
1.10
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.75
Price X volume
558.40K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.21 | 46.09 | Cheaper |
| Ent. to Revenue | 0.49 | 14.34 | Cheaper |
| PE Ratio | - | 30.41 | - |
| Price to Book | 1.90 | 6.21 | Cheaper |
| Dividend Yield | - | 1.78 | - |
| Std. Deviation (3M) | 90.74 | 64.12 | Riskier |
| Debt to Equity | 0.28 | -145.53 | Expensive |
| Debt to Assets | 0.11 | 0.35 | Cheaper |
| Market Cap | 4.27M | 9.70B | Emerging |
